Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- Practice Fusion announces first VP of product management
Electronic medical record company Practice Fusion appointed former athenahealth executive Edwin Miller as its first VP of product management. Practice Fusion is the fastest growing EMR community in the U.S., according to company officials.
This latest announcement comes on the heels of the San Francisco-based company’s recent achievement of full federal certification as a complete EHR provider by the Office of the National Coordinator of Health IT.
- ViaCyte appoints former Edwards manager to VP of device research and development
ViaCyte Inc. named Michael Scott VP of device research and development today, where he will oversee all development and manufacturing activities including design, engineering, and testing while contributing to regulatory matters. Scott comes to the San Diego-based diabetes-focused cell therapy company from Edwards Lifesciences, where his most recent role was as senior director of engineering for heart valve therapies.
- Allegro assigns new president & CEO
Allegro Diagnostics appointed Michael Webb as president & CEO and added him to the company’s board of directors. Webb brings more than 25 years of leadership experiences in the biomedical industry to the Maynard, Mass.-based diagnostics company.
- HeartSine names new president
HeartSine Technologies Inc. announced that William McChesney will take over as president for the personal and public defibrillator company, succeeding Gregory Cash who served as president for four years. McChesney is a 30-year veteran of financial, manufacturing and service in industries including healthcare and telecommunications in Europe, the U.S., Asia and Australia.
- Freeland Systems adds a new VIP of sales, marketing and business development
Freeland Systems announced the appointment of Michael Kingcaid as VP of sales, marketing and business development. Kingcaid brings 30 years of experience in complex medical hardware and software sales to the Venice, Fla.-based imaging technology company.
- RepRegen chairman resigns
Dr. Stephan Rietiker resigned as chairman of Switzerland-based RepRegen, citing "significant and competing workload and responsibilities" as the reason for his departure.
- Hotspur names its first board chairman
Mountainview, Calif.-based Hotspur Technologies announced the appointment of Fred Khosravi as chairman of the board for the catheter-based technologies company. Khosravi is a Hotspur cofounder and served on the board prior to being appointed to the newly created chairman position.
- Cleveland Clinic’s medical director for cardiac intensive care shifts to Summa Cardiovascular
Dr. Marc Penn resigned as medical director of cardiac intensive care to serve as director of research at Summa Cardiovascular Institute and professor of medicine and integrative medical sciences at Northeast Ohio Medical University.
- Generex appoints CEO for post-spinout Antigen Express
Generex Biotechnology Corp. (OTC:GNBT) announced the appointment of Jos van der Woert as CEO of its wholly-owned subsidiary Antigen Express Inc. following its spinout as a stand-alone public company. van der Woert brings extensive experience in the oncology arena to the Worcester, Mass.-based cancer vaccine platform technology maker.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.